Asthma, Allergic Completed Phase 2 Trials for Roflumilast (DB01656)

Also known as: Atopic Asthma / Allergic Asthma / Asthma extrinsic / Extrinsic asthma / Asthma / Asthma, unspecified / Asthma bronchial / Asthma NOS / Asthmatic / Br. asthma / Bronchitic asthma

IndicationStatusPhase
DBCOND0047182 (Asthma, Allergic)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01365533A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic AsthmaTreatment